The Interplay Between Health Disparities and Acceptability of Virtual Reality: A Survey Study.

chronic pain clinical trial digital therapeutics health disparities orofacial pain virtual reality

Journal

Cyberpsychology, behavior and social networking
ISSN: 2152-2723
Titre abrégé: Cyberpsychol Behav Soc Netw
Pays: United States
ID NLM: 101528721

Informations de publication

Date de publication:
01 Aug 2024
Historique:
medline: 1 8 2024
pubmed: 1 8 2024
entrez: 1 8 2024
Statut: aheadofprint

Résumé

Virtual reality (VR) has emerged as a nonpharmacological adjuvant to manage acute and chronic pain symptoms. The goal of this survey study was to determine the acceptability of VR among chronic pain participants hailing from distressed and prosperous neighborhoods in the state of Maryland. We hypothesized that pain severity and interference vary in groups experiencing health disparities, potentially influencing VR's acceptability. From March 11 to March 15, 2020, we surveyed a cohort of clinically phenotyped participants suffering from chronic orofacial pain. Participants were asked to express their willingness to participate in a longitudinal VR study and their expectation of pain relief from using VR. Seventy out of 350 participants with chronic pain completed the survey (response rate: 20%). There was no difference in the likelihood of responding to the survey based on their neighborhood distress. Among survey respondents and nonrespondents, similar proportions of participants were from distressed neighborhoods. Among the respondents, 63 (90%) and 59 (84.3%) were willing to participate and expected to experience pain relief from the VR intervention, respectively. Age, sex, race, neighborhood distress, severity of pain, and prior VR experience did not influence willingness to participate in the VR trial or the expectations of VR-induced improvement. These findings suggest that VR as an adjuvant intervention is potentially accepted by chronic pain participants, irrespective of neighborhood-level social determinants of health.

Identifiants

pubmed: 39088356
doi: 10.1089/cyber.2023.0694
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Nandini Raghuraman (N)

Department of Pain and Translational Symptom Science, School of Nursing, University of Maryland, Baltimore, Maryland, USA.
Graduate Program in Life Sciences, Program in Epidemiology and Human Genetics, School of Medicine, University of Maryland, Baltimore, Maryland, USA.

Theresa Bedford (T)

711th Human Performance Wing, En Route Care, Wright-Patterson AFB, Ohio, USA.

Nhi Tran (N)

Department of Pain and Translational Symptom Science, School of Nursing, University of Maryland, Baltimore, Maryland, USA.

Nathaniel R Haycock (NR)

Department of Pain and Translational Symptom Science, School of Nursing, University of Maryland, Baltimore, Maryland, USA.

Yang Wang (Y)

Department of Pain and Translational Symptom Science, School of Nursing, University of Maryland, Baltimore, Maryland, USA.
Placebo Beyond Opinions Center, University of Maryland, Baltimore, Maryland, USA.
Center to Advance Chronic Pain Research, University of Maryland, Baltimore, Maryland, USA.

Luana Colloca (L)

Department of Pain and Translational Symptom Science, School of Nursing, University of Maryland, Baltimore, Maryland, USA.
Placebo Beyond Opinions Center, University of Maryland, Baltimore, Maryland, USA.
Center to Advance Chronic Pain Research, University of Maryland, Baltimore, Maryland, USA.
Department of Anesthesiology & Psychiatry, University of Maryland, School of Medicine, Baltimore, Maryland, USA.

Classifications MeSH